Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fluorescence detection-based functional assay for high-throughput screening for MraY.

Thérèse Stachyra1, Christophe Dini, Paul Ferrari

  • 1Aventis Pharma France, 93235 Romainville, France.

Antimicrobial Agents and Chemotherapy
|February 26, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From TDP-43/RNA complex formation to disease-linked TDP-43 aggregation through a structural and cellular approach.

Nature communications·2026
Same author

Toward Unified Biomarkers for Focal Epilepsy.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2025
Same author

Centromedian nucleus targeting in the pediatric population treated with thalamic responsive neurostimulation for drug-resistant epilepsy.

Epilepsia open·2025
Same author

Thalamic highways as a bridge to neuromodulation.

Brain : a journal of neurology·2025
Same author

TDP-43 nuclear retention is antagonized by hypo-phosphorylation of its C-terminus in the cytoplasm.

Communications biology·2025
Same author

Neural Decoding of Spontaneous Overt and Intended Speech.

Journal of speech, language, and hearing research : JSLHR·2024
Same journal

Isavuconazole for invasive mold disease in patients with hematological malignancies: a multicenter real-world study from China on efficacy, safety, and competing risks.

Antimicrobial agents and chemotherapy·2026
Same journal

An Achilles' heel for methicillin-resistant <i>Staphylococcus aureus</i>? Re-evaluating β-lactam susceptibility of MRSA.

Antimicrobial agents and chemotherapy·2026
Same journal

Essential role of glycogen synthase kinase 3 in regulating growth, drug response, and infectivity in <i>Leishmania infantum</i>.

Antimicrobial agents and chemotherapy·2026
Same journal

<i>In vitro</i> antibacterial activity of gepotidacin in combination with other antimicrobial agents against <i>Neisseria gonorrhoeae</i> isolates.

Antimicrobial agents and chemotherapy·2026
Same journal

Development of domain-specific probes of <i>Plasmodium falciparum</i> heat shock protein 70-1.

Antimicrobial agents and chemotherapy·2026
Same journal

Addressing therapeutic options for KPC-3-producing ST307-<i>Klebsiella pneumoniae</i>: insights from <i>in vitro</i> evolution and mutant prevention strategies.

Antimicrobial agents and chemotherapy·2026
See all related articles

Researchers created a new assay to study MraY, an enzyme crucial for bacterial cell wall peptidoglycan synthesis. This assay uses a fluorescent substrate and can be adapted for high-throughput screening of potential inhibitors.

Area of Science:

  • Biochemistry
  • Microbiology
  • Enzymology

Background:

  • MraY is a key enzyme catalyzing the initial membrane-associated step in bacterial peptidoglycan biosynthesis.
  • Peptidoglycan is essential for bacterial cell wall integrity and is a target for antibiotics.

Purpose of the Study:

  • To develop a novel, specific assay for MraY enzyme activity.
  • To enable high-throughput screening of MraY inhibitors for potential therapeutic applications.

Main Methods:

  • Utilized UDP-MurNAc-N(epsilon)-dansylpentapeptide, a fluorescently labeled substrate analogue.
  • Employed a partially purified MraY enzyme preparation from an overproducing Escherichia coli strain.
  • Developed two assay formats: one involving HPLC separation and another a non-separation, fluorescence-based, high-throughput method.

Related Experiment Videos

Main Results:

  • Successfully developed and validated two distinct assay formats for MraY.
  • The high-throughput assay leverages differential fluorescence properties of substrate and product.
  • Validated the assay's efficacy using known natural and synthetic MraY inhibitors.

Conclusions:

  • The novel MraY assay provides a specific and adaptable tool for enzyme characterization.
  • The high-throughput format facilitates efficient screening of potential antibacterial compounds targeting peptidoglycan synthesis.